• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Medical Device Market
    Medical Device News
    Medical Device Stocks
    • Medical Device Market
    • Medical Device News
    • Medical Device Stocks
    medical-device-investing

    Natus Medical Announces First Quarter Financial Results

    Gabrielle Lakusta
    Apr. 25, 2018 08:58AM PST
    Medical Device Investing

    Natus Medical (NASDAQ:BABY) today announced financial results for the three months and full year ended March 31, 2018. As quoted in the press release: For the first quarter ended March 31, 2018, the Company reported revenue of $128.6 million, an increase of 3.1% compared to $124.7 million reported for the first quarter 2017. Revenue for the first quarter …

    Natus Medical (NASDAQ:BABY) today announced financial results for the three months and full year ended March 31, 2018.

    As quoted in the press release:

    For the first quarter ended March 31, 2018, the Company reported revenue of $128.6 million, an increase of 3.1% compared to $124.7 million reported for the first quarter 2017. Revenue for the first quarter of 2017 included $9.0 million from our contract with the government of Venezuela which did not reoccur in 2018. GAAP gross profit margin was 55.7% vs. 53.5% in the first quarter 2017. GAAP net loss was $3.1 million, or $0.10 per share, compared with GAAP net income of $0.3 million, or $0.01 per diluted share in the first quarter 2017.

    Non-GAAP earnings per diluted share was $0.24 for the first quarter 2018, compared to $0.30 in the first quarter 2017. Non-GAAP net income was $8.0 million for the first quarter 2018 compared to the prior year’s first quarter non-GAAP net income of $9.8 million. Non-GAAP gross profit margin was 59.0% vs. 57.8% reported for the first quarter of 2017.

    The Company repurchased $4.7 million of its stock and repaid $25.0 million of outstanding debt during the first quarter of 2018.

    Click here to read the full press release.

    medical-device-investingfinancial-results
    The Conversation (0)

    Go Deeper

    AI Powered

    Medtronic reports full year and fourth quarter fiscal 2023 financial results; announces dividend increase

    Amphenol Reports First Quarter 2024 Results and Announces New Stock Repurchase Program

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Medical Device Investing Stocks

    Cardiex Limited

    Cardiex Limited (CDX:AU)
    CDX:AU

    Cleo Diagnostics

    Cleo Diagnostics (COV:AU)
    COV:AU

    Applied UV

    Applied UV (AUVI:NSD)
    AUVI:NSD

    Avricore Health

    Avricore Health (AVCR:CC)
    AVCR:CC
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES